Coherus Biosciences (CHRS) PT Raised to $25 at Citi
Tweet
Share
E-mailGet Alerts CHRS Hot Sheet
Price: $1.41 +2.92%
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Join SI Premium – FREE
Citi raised its price target on Coherus Biosciences (NASDAQ: CHRS) to $25.00 (from $23.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- Dell (DELL) PT Raised to $500; TD Cowen: 'Phenomenal Results & Guidance'
- MongoDB (MDB) PT Lowered to $450 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
